Subscribe to Newsletter

Content by Phoebe Harkin:

Subspecialties Business and Innovation

Business in Brief

| Phoebe Harkin

The latest industry news – in 60 words or less

Subspecialties Basic & Translational Research

So Long, Lazy Eye

| Phoebe Harkin

Is subanesthetic ketamine the cure for amblyopia?

Business & Profession Glaucoma

A Life Well Lived

| Phoebe Harkin

Celebrating the legacy of Alan S. Crandall

Business & Profession Glaucoma

On Kindness

| Phoebe Harkin

We remember a giant of ophthalmology, Alan S. Crandall

Business & Profession Business and Innovation

Business in Brief

| Phoebe Harkin

The latest industry news, appointments and acquisitions – in 65 words or less

Subspecialties Retina

Tube Talk

| Phoebe Harkin

Researchers discover a communication structure that is essential for fully functional retinal cells

Subspecialties COVID-19

The Trouble with Triage

| Phoebe Harkin

Do asymptomatic COVID-19 patients pose a risk to ophthalmologists during elective examinations?

Business & Profession COVID-19

The Kids Are (Not) All Right

| Phoebe Harkin

With 75 million children to serve, America’s pediatric ophthalmologists face a tough task – and they are struggling to cope in the wake of COVID-19

Subspecialties Health Economics and Policy

Pounds of Pain

| Phoebe Harkin

Fight for Sight has partnered with the London School of Economics to highlight the personal and financial cost of sight loss in the UK

Subspecialties Cornea / Ocular Surface

Ready, Steady, Graft

| Phoebe Harkin

Novel stem cell technique offers hope for chemical burn victims

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: